Company News
Gujarat Themis Acquires MicroBioPharm Japan for ₹1,351 Cr
Gujarat Themis Biosyn acquired MicroBioPharm Japan for ₹1,351 crore, expanding into fermentation-based CDMO services with access to Japanese market.
MBJ reported FY26 revenue of ₹557 crore with 25% EB